| CTRI Number |
CTRI/2024/10/075682 [Registered on: 23/10/2024] Trial Registered Prospectively |
| Last Modified On: |
22/10/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Ayurveda |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
Effect of ayurvedic Ointment in piles |
|
Scientific Title of Study
|
Randomised Controlled clinical study to evaluate the efficacy of Pippalyadi ointment in Arsha with special reference to 1st and 2nd degree internal haemorrhoids |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Rohan Mansing Valvi |
| Designation |
PG Scholar |
| Affiliation |
Ayurved Seva sangh Ayurved Mahavidyalaya, Ganeshwadi Nashik |
| Address |
Ayurved Seva sangh Ayurved Mahavidyalaya, Ganeshwadi Nashik
Nashik MAHARASHTRA 422003 India |
| Phone |
7020050977 |
| Fax |
|
| Email |
rohanvalvihtc@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Santosh Pathak |
| Designation |
PG Guide |
| Affiliation |
Ayurved Seva sangh Ayurved Mahavidyalaya, Ganeshwadi Nashik |
| Address |
Ayurved Seva sangh Ayurved Mahavidyalaya, Ganeshwadi Nashik Ayurved Seva sangh Ayurved Mahavidyalaya, Ganeshwadi Nashik Nashik MAHARASHTRA 422003 India |
| Phone |
7767939759 |
| Fax |
|
| Email |
drsantoshsp@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Santosh Pathak |
| Designation |
PG Guide |
| Affiliation |
Ayurved Seva sangh Ayurved Mahavidyalaya, Ganeshwadi Nashik |
| Address |
Ayurved Seva sangh Ayurved Mahavidyalaya, Ganeshwadi Nashik Ayurved Seva sangh Ayurved Mahavidyalaya, Ganeshwadi Nashik Nashik MAHARASHTRA 422003 India |
| Phone |
7767939759 |
| Fax |
|
| Email |
drsantoshsp@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
Dr Rohan Mansing Valvi |
| Address |
Ayurved Seva sangh Ayurved Mahavidyalaya, Ganeshwadi Panchavati Nashik 422003 |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Rohan Mansing Valvi |
Arogyshala Rugnalaya |
OPD no 6 Shalyatantra OPD Ayurved Seva Sangh Ayurved Mahavidyalaya Ganeshwadi Nashik Nashik MAHARASHTRA |
7020050977
rohanvalvihtc@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee Ayurved Seva Sangh Ayurved Mahavidyalaya, Nashik |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:K640||First degree hemorrhoids. Ayurveda Condition: ARSAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Comparator Arm | Drug | Other than Classical | | (1) Medicine Name: X piles ointment , Reference: NA, Route: Topical, Dosage Form: Malahara/ Ointment/ Balm, Dose: 1(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 15 Days, anupAna/sahapAna: No, Additional Information: - | | 2 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Pippalyadi Ointment, Reference: Sushrut Chikitsasthana 12/9, Route: Topical, Dosage Form: Malahara/ Ointment/ Balm, Dose: 1(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 15 Days, anupAna/sahapAna: No, Additional Information: - |
|
|
|
Inclusion Criteria
|
| Age From |
20.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Both |
| Details |
Patient Dignosed with I & II degree of Internal Haemorrhoids of both sexes
Patients having following Clinical features of Arsha Raktshrav Saraktamalpravruti Gudashool Gudakandu Patients willing to participate with informed written consent |
|
| ExclusionCriteria |
| Details |
Diagnosed case of Carcinoma of rectum large intenstine prolpase of
rectum rectalpolyps fissure in ano fistula in ano crohns disease
Pregnant women and lactating mother
Severe anaemic patient
Patients having systemic disorders like portal hypertension liver cirrhosis
Patient having immuno compromised disorders
Bledding disorders like haemophillia and purpura |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
An Open list of random numbers |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Reduction in pain and bleeding from 1st and 2nd degree internal haemorrhoids |
15 days |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Reduction in discomfort |
15 days |
|
|
Target Sample Size
|
Total Sample Size="80" Sample Size from India="80"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2 |
|
Date of First Enrollment (India)
|
11/11/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Current study is based on
studying the effect of ayurvedic medicated ointment in first and second degree
internal haemorrhoids. 80 patients will be selected for the study . Patients
will be divided in two groups , group a will be treated with pippalyadi ointment
for 15 days and group b will be treated with x-piles ointment or 15 days.
Discussion will be made based on the assessment done with reduction in pain via
vas scale and per rectal bleeding. |